Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG
Trls-04. Early insights from pnoc027: personalized treatment approaches based on real-time drug screening and genomic testing in pediatric and adolescent patients with recurrent medulloblastoma
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.
This site uses third-party website tracking technologies to provide and continually improve our services, and to
display advertisements according to users’ interests. I agree and may revoke or change my consent at any time
with effect for the future. More